Expertise in
7
conditions

Joachim Quernheim-Muller

Freiburg, BW, DE 
Expertise in
7
conditions
Freiburg, BW, DE 

Overview

Joachim Quernheim-Muller practices practicing medicine in Freiburg, Germany.

Mr. Quernheim-Muller is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Beryllium Disease, Interstitial Lung Disease, Lung Transplant, and Endoscopy.

He is actively involved in clinical research, co-authoring 106 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Freiburg, BW 79106, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
View 1 Less Clinical Trial

106 Total Publications

PDE-4 Inhibition in Sarcoidosis Patients: A Retrospective Single-Center Analysis of 51 Patients.
PDE-4 Inhibition in Sarcoidosis Patients: A Retrospective Single-Center Analysis of 51 Patients.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 01, 2025

Frequently Asked Questions about Joachim Quernheim-Muller

Is Joachim Quernheim-Muller a top-rated expert for Sarcoidosis?

MediFind is an objective health platform that identifies experts based on real-world data. Joachim Quernheim-Muller is classified as an Elite expert for Sarcoidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Joachim Quernheim-Muller participate in research or clinical trials?

Yes. Joachim Quernheim-Muller has published 106 articles and abstracts on conditions like Sarcoidosis. You can view a list of Joachim Quernheim-Muller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Quernheim-Muller's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile